CMPS

cheekytikiroom

CMPS with product release imminent.

twiggs462

Psychedelics will make the next ones this year. Look at $DFTX $ATAI and $CMPS

Nearby-Actuator4641

CMPS for sure

occamism

$CMPS is likely to produce the biggest return by end of year.

CouchPotatoFamine

Been spreading things around a bit with 100 share purchases of relatively risky ideas in hopes they will bounce up a bit soon. Selling some covered calls on said positions too, things like CMPS, PATH & UPST. Why those? People on here had thesis on them I found pretty sound. Oh, also loaded up on VRRM because I feel like that company was brutalized for losing a major client and think they will regain at least $4 a share in the next few months.

swingworkstheoracle

CMPS

RadiantPerception224

$CMPS Compass Pathways about to get the first ever psychedelic drug approval

TeslasElectricBill

Funny, my fumble was $ASTS where I bought $5 calls when it was $4 then auto-sold it with 100% profit via a limit order cuz it was down like 80% for 5+ months and I was getting paranoid and wanted out. 2 weeks later my limit order goes through because they partnered with Verizon/AT&T and the stock hit $40+ and kept going to $90+ and it still kills me cuz I fumbled it so hard and left life changing money on the table. Luckily now I bet big on $CMPS and I'm already up 300%+ and will likely hit 600%+ however the biggest issue is my short term capital gains taxes will be ~50% 🫣😬

Capable-Mark-7554

psychedelics stocks (CMPS) mark my words, this is going to 20+ by end of year. you read it here first!

stevenryl866

A week ago, I posted on GETY and it’s around 0.8xx and now at 1.0. I give you another which is under CMPS. This is the only one closest to approval and commercialisation. Spravato under Johnson & Johnson is the only psychedelic FDA approved. 2025 alone generated around 1.7bil of annualized sales. Next catalyst in Early Q3 release of phase durability result, of good pump to 40. FDA approved in 2027, pump to 90. In between if buyout we go 70. CMPS also have the following designation and including the recent one after Trump EO on psychedelic. Prior to Trump EO, it trading between 5-6 per share. Breakthrough Therapy Designation (BTD) for treatment-resistant depression (TRD). In addition, it has several other important FDA-related regulatory advantages/supports: * NDA Rolling Review granted by FDA in 2026. * Commissioner’s National Priority Voucher (CNPV) awarded in 2026 to accelerate review timing. * FDA accepted IND application for PTSD study expansion. Outside the US FDA: COMP360 also received the UK’s ILAP (Innovative Licensing and Access Pathway) designation.

Suitable-Increase-38

I think people overlook one very important factor when comparing Atai to CMPS. I hear a lot about the duration of the session, and that is true, but what no one talks about is the intensity of the drug. A lot of people have tried psilocybin and are familiar with its effects. 5meo is a whole different animal and many people are scared of it. I think CMPS has a much easier road to adoption because of this. 

TeslasElectricBill

I'm an options newbie and anything other than basic calls makes me nervous as I do not understand it well. With that said I have a lot of options expiring in Jan 2027 on $CMPS and since it's short term gains, I'm looking at 50% taxes on my gains UNLESS I exercise the options to shares then hold onto another 365 days, at which point taxes will be 20% less. I think I'm gonna exercise if $CMPS is on it's way to $40 potentially cuz that's life changing money for me!

TeslasElectricBill

$40 would be life-changing money for me and in order to prevent 50% of taxes and to hold onto more CMPS stock, I think I'm most likely going to exercise my options before expiration in January 2027 and sit on my ass for another year hoping the stock pops even more and so I could pay 20% less taxes on my gainz. God speed and best of luck to both you and me OP.

mycasestudygroup

thoughts on CMPS - have 10k i need to put somewhere and forecast looks good.

stevenryl866

JUNS you better read on Trump EO on the psychedelic medicine. As of now only one approved psychedelic in market, its Spravato and under Johnson & Johnson. The 2nd upcoming and closest to approval is under ticker CMPS. JUNS have nothing even close to it, it’s still months or years for them to get any FDA designation. JUNS paid 600k in escrow account and if 90days fails, PharmaAla get the deposit. the “$100M term sheet” headline is somewhat misleading because: * the immediate commitment is only a few million dollars * the rest is conditional and may never be paid if development fails.

ZombieSkipper

CMPS

Blistorious

CMPS 🍄 on fire!!

Nearby-Actuator4641

After a lot research and about CMPS DAY BY DAY I SEE, (GAD) is increasingly viewed by investors as a potentially very important future opportunity for CMPS, BECAUSE * FDA/regulatory momentum is improving, * cash runway is solid, * and the mental health market opportunity is enormous. So I think and also believe CMPS approaching the stage where: * partnerships are available, * licensing deals are on the way, * strategic investments,

PrincessJellyfish17

CMPS

softboiledjadepotato

Rooting for CMPS tomorrow!!!

Capable-Mark-7554

CMPS. You read it here first or on shroom stock sub

occamism

CMPS is going to re-rate in a big way in the coming months. Even with the vouchers awarded, they're likely 1-2 years ahead of the next competitor in reaching commercialization. That timeline moat is meaningful. There's nothing stopping CMPS from taking this extra time to develop their own faster acting versions that will make it much more difficult to displace them once they've been accepted as the go to treatment. Their Phase IIIa readout was actually better than most realize because it was against a 1mg live dose placebo. The 3.8 madrs score is actually a 4.8-5.8 when adjusted for a sugar pill placebo. Those are significant numbers. The drug works. They also intentionally chose to pursue the longer delivery process in lieu of a faster acting version because they believe it is more effective. The upcoming FDA approval may require all players in this space to provide prolonged delivery chaperones until more data is available proving the faster acting versions perform with the same or better efficacy.

SocialSoundSystem

I bought in/out of CMPS a long ass time ago bc of Hamilton Morris but it just didn’t go anywhere. Of course now it moves years later. Is he still working there? Guy is a shark.

BattleSensitive3467

With ATAI you don't need talk therapy, with CMPS you do

DelfDrizz

I'm in on CMPS for the long haul - started buying around their low last year @2.50 and have been loading up ever since. I wasn't trading anything until 2024, so I wasn't around for their peak, but after trying similar drugs to their COMP360 (iykyk) I fully believe in the future of the company/drug, and can see the share price easily hitting 10-20+ in a year or two. Especially with how favorable public perception is turning towards these kinds of drugs!

UnfairRazzmatazz987

The reason for that is Atai has more molecules but CMPS is much further along in getting approved. I think CMPS is really undervalued because this one molecule could treat everything Atai is treating. Anyone who has tried psilocybin knows it works. I think this is a no brainer.

call_me_soup69

ATAI is developing BPL-003 which takre an hour for treatment. CMPS is developing COMP360 which takes 6-8 hours. ATAI also has stakes in several other companies and molecules I the same space. Right now CMPS market cap is 1.2b, ATAI 1.6b. CMPS already ran it's price up on the NPV news, ATAI did not get a voucher so still has significant room to run imho.

UnfairRazzmatazz987

It ran up 40% before the voucher was even promised to them. I see it consolidating and flying as this progresses. I also like Atai too. CMPS and ATAI are the only psych stocks I own.

Sledgahammer

ATAI has twice the market cap of CMPS for a similar product and identical target demographic?

call_me_soup69

That's true, but CMPS ran up like 40% on the voucher news. ATAI has more molecules in the pipeline with significantly quicker acting effects. CMPS is also now facing direct competition from non-profit Osana Institute which also received an NPV for psilocybin. FWIW I love CMPS and am loading up on them as well.

UnfairRazzmatazz987

I see where you are coming from but CMPS is significantly closer to FDA approval

sourchicken39

Seastar Medical (ICU): revolutionary technology to treat a common problem (it’s like a dialysis machine for your inflammation cells). Already approved for pediatrics. Will bump again when approved for adults, trial currently undergoing Otherwise psychedelics: ATAI, CMPS, DFTX

occamism

CMPS Compass Pathways - They're the first mover in the psychedelics for mental health space. Just won an FDA fast track CNPV voucher to significantly shorten full FDA approval. Great phase 3 clinical trial results with only the long term phase 3 trial results remaining. All signs point to another great final readout. Massive cash runway into 2028. Consensus 3x+ candidate by the end of 2026.

MtGloomy0420

$CMPS was confirmed for what?

ReelTech

Solid basket mentioned by SnozzberryBoom (CMPS, HELP, ATAI, DFTX) plus the three you listed. Thing to watch with FDA-fast-track news on psychedelics is the gap between headline and actual IND submissions - the larger names (CMPS especially) tend to hold their gains on these catalysts while the smaller OTC ones often give most of it back within a couple weeks once volume fades. CMND is interesting because the Israel-based trials tend to run faster than US so there should be real data flow by Q3. Position sizing matters way more than picking on these, I usually cap single psychedelic names at 2% portfolio because the clinical-readout outcome distribution is bimodal and ugly.

happy123z

My CMPS and ATAI calls are printing

Ugadawg7

CMPS awarded fast track by fda

SnozzberryBoom

HELP, CMPS, DFTX, ATAI are all major players in the industry

MutaliskGluon

My guy also called a big CMPS move up a couple weeks ago. Also called for new ATHs in SPY in early april. Hes also now calling for a dump in the next week or two. I imagine that one he will get wrong since markets cant go down since an ever worsening oil crisis is bullish

theinquisition

No, you are looking at the wrong ticker. I want to know what strike date a 7 dollar put on CMPS has the highest profit chance.

theinquisition

No i kean CMPS

Fit_Square_520

Anyone making a play on CMPS?

Hellmale

Bought HOOD dips, SOFI, HELP, CMPS, STIm

rookieswagg

And CMPS is up 80% now lol

Bitter-String-3645

CMPS over 10 overnight And also CAR 621... insane squeeze is continuing

happy123z

I do long calls on bio stocks that I like but don't love and my CMPS was up 1500%today haha. ATAI up 400%

darkphenom67

$CMPS just got a $70 PT 😭😭😭 that’s more than 600% upside

Accomplished-Tower74

DFTX,CMPS,ATAI- top psychedelic stocks

LemurianAdvantage

I really like CMPS.

Hellmale

People are not interested in Psychedelics anymore?😆 I thing after 🥭 signed executive order , CMPS, HELP, GHRS are mooning . The question is “ can they compete with ABBV or LLY?”

Hellmale

Made almost $900 from HELP and CMPS stocks only. I think they have really big potential going up parabolic🚀

MechingMyWayDowntown

Bro you seeing CMPS and ATAI?

MechingMyWayDowntown

CMPS is on a tear today with reasonable stability between 40-50%, meeting resistance at double digits!

Nichtszuhaben

CMPS

LemurianAdvantage

Go go Compass Pathways (CMPS)

Prestigious-Fix8154

Psychedelics stocks went crazy-->CMPS, HELP, DFTX, ATAI

darkphenom67

exactly, i can see CMPS going to $25 EOY easily. i found out today that peter thiel invested in both 😭😭

Ugadawg7

Phase 3 trials in CMPS and soon for ATAI.... People comparing to tilray have no idea

darkphenom67

Anyone who thinks the psychedelic stocks are pump and dumps don’t know how much upside these stocks have. Of course there’s a good amount of risk but if you do your research and choose a winner it can be a 10x no doubt. $CMPS my favorite, $ATAI second best, $PBM solid too. There are a lot of others too I haven’t looked as closely into those.

darkphenom67

$CMPS and $PBM only psychedelic stocks worth buying but $CMPS has more upside now because $PBM ran up so much, but still have a lot of potential.

darkphenom67

psychedelic stocks are going insane after trump executive order, i just bought $3k of $CMPS

Tiptaptommy

$CMPS - likely to get the voucher with the executive order

No_Cantaloupe8848

CMPS- surprised no one in this sub is talking about it. Up 20% pre-market.

Scary-Leather2050

DFTX, ATAI, CMPS. Trumps execute order has them blowing up

poppybellx

CMND CMPS halted up! Trump signed executive order for psychedelic drugs!

Hellmale

Market order placed for : HELP, CMPS, GHRS

volckerwasright

No, the real pump is in psychedelics right now. Check out ATAI CMPS

volckerwasright

ATAI ripper CMPS ripper

volckerwasright

Look at ATAI look at CMPS, shrooms bout to run so hard

MechingMyWayDowntown

Thiel is in CMPS and ATAI

MechingMyWayDowntown

Of all of them, Compass Pathways has the most recently completed compiled and published phase 3 data at 26 week endpoint with successful numbers (something like 76% of treatment resistant, depression patients in full remission 6 months after a single treatment or two treatments). They already announced in an earlier press release this year that they are on track for commercialization in 2027 and planned on a rolling NDA submission this year with the FDA in Q4. ATAI has the most drug variants in the pipeline, but CMPS is set to be first across the line

Mediocre-Load-3305

CMPS- developing a synthetic psychedelic drug, stock should pop some more on POTUS easing of pathway for psychedelics to be widely therapeutically available

twiggs462

Well psychedelics got an Executive Order to move forward and DFTX, ATAI and CMPS will likely go brrrrrrrr

twiggs462

DFTX, ATAI, CMPS... those are the three unicorns here.

-PsillyFunGuy-

Anybody interested in getting in on this should check out r/shroomstocks. Long-standing community with a lot of good news/info and discussion. As with any subreddit, plenty of bad info too, so up to you to be discerning. There are only a handful of standout companies in this space: CMPS (psilocybin for treatment resistant depression) - finished second phase 3 trial with positive data, submitting NDA later this year, widely expected to receive an FDA priority voucher next week..also starting phase 3 trial for PTSD this quarter DFTX (LSD for major depressive disorder and general anxiety disorder) - has three phase 3 trials concluding this year and not far behind CMPS in terms of timeline to approval, also generally expected to get a voucher this week ATAI (namely 5-Memo-DMT for TRD, as well as 2-3 other psychedelic molecules in trial) - beginning first phase 3 trial of their main drug this quarter I believe HELP (deuterated psilocin for MDD…and N,N-DMT for GAD) - phase 3 data from psilocin trial coming Q4 2026

RadiantPerception224

This was not baked in on Thursday at all. $CMPS, $ATAI, $HELP and Definium will all benefit

Crazy_Donkies

Psychedelic stocks.  ATAI.  CMPS.  GHRS.  CYBN.  MNMD. I'm in none of them and we should have been in them Friday, but here you go.  

Apollo506

Don't leave out Cybin! Which is now Helus Pharma (HELP). I hold both CMPS and HELP; I believe that CMPS will be first to approval for depression but that HELP'S CYB-003 is a better molecule.

stevenryl866

CMPS the only one with late stage, most advanced one and breakthrough designation

Ok_Ground9015

**Compass Pathways (CMPS):** A major player in the space, they are in Phase 3 trials for **psilocybin therapy** (COMP360) for treatment-resistant depression. Despite some previous regulatory friction, they are a primary candidate for the FDA's new "priority vouchers" mentioned in the order. **AtaiBeckley (ATAI):** Formed through the merger of Atai Life Sciences and Beckley Psytech, this company is researching several compounds, including **5-MeO-DMT** and **ibogaine** derivatives. Their stock saw significant movement following the announcement. **Beond, Inc.:** A U.S.-based company specializing in **ibogaine-assisted therapies**. They recently established a headquarters in Austin, Texas, and issued a statement confirming their intent to provide the "gold-standard" clinical model for the research framework established by the order. **Helus Pharma (formerly Cybin):** Recently rebranded in early 2026, Helus is advancing HLP003 (a proprietary psilocybin analog) through two pivotal Phase 3 studies. They already hold an FDA Breakthrough Therapy Designation, making them a direct beneficiary of the order's mandate to "dramatically accelerate" access. **Definium Therapeutics & Psyence Biomedical:** Both companies are actively conducting research on psychedelic-derived treatments for mental health and were highlighted by market analysts as key entities affected by the administration's policy shift.

suture-self

ATAI raises capital through CMPS shares. They are down to around a ~5% stake.

zerofrakhere

Come on CMPS yes!!

cock_pussy

Calls on CMPS for WSB’s psychedelic therapy

Cptjoe732

Your logic is sort of flawed here. Cmps addressed the short vs long acting therapy. This is a fragile portion of the population here. You don’t want someone screaming in a chair while you have 4-5 patients waiting in the lobby. Cmps can bill for each hour vs a high turnover rate. Also Atai and Ghrs haven’t even had larger studies like Compass, 80 people vs 800. Those madrs numbers are going to drop with larger studies. I believe CMPS had something like a 5 point reduction in phase 2 that’s why it tanked in phase 3 bc it was not what the market was anticipating. These people are not going back to work after getting these treatments. The winner is going to be who has the most durability. Yes CMPS has a longer treatment time but they have proved to have a very long durability. Don’t fall for the shorter compound story when they haven’t even had robust studies yet. Cmps is already planning on commercialization vs these guys who are not even at phase 3.

Cptjoe732

I love that I posted this months ago and the retards in here said you could get shrooms behind a dumpster. Can’t wait to them to landscape my lawn. Long $CMPS $ATAI

amberlight3

ATAI also has a large position in CMPS. So an investment in ATAI gives you exposure to both.

volckerwasright

CMPS will get one of those 3 vouchers

amberlight3

CMPS got to Phase 3 first but “further along” isn’t “better positioned.” The killer issue is treatment duration. CMPS psilocybin requires 4-6 hours of supervised clinic time. GHRS GH001 takes ~11 minutes, discharge-ready within 1 hour. That’s 8-10 patients per chair per day vs 2. Payers and clinic operators will do that math real fast. The data also isn’t close. GH001 Phase 2b showed -15.5 point MADRS reduction vs placebo with 57.5% remission at Day 8 and zero serious adverse events. CMPS COMP360 had fading efficacy by week 12 and suicidal ideation flags. GHRS published in JAMA Psychiatry. Sell-side: 9/9 Buy on GHRS, 14/14 Buy on ATAI. CMPS consensus is mixed. I’d rather own the best data entering Phase 3 than the worst data already in Phase 3.

TraditionalSundae990

CMPS? seems further along than these two

stringtheory28

Off the top of my head, CMPS. And one look at the chart shows insane volume on Thursday. More insider BS from the White House.

tutah

Anyone buying CMPS?

BurningandLooting

Psychedelic therapeutic stocks, ATAI and CMPS also doing well past year after taking big dumps post IPO. Lots of trials in the works and potential for big boys to scoop them up.

rookieswagg

Also not financial advice but look into UNCY and CMPS if you want some semi-casino but huge upside plays, got all my regard savings in there

dvdmovie1

"sub it seems like a casino where everyone’s too emotionally invested." That's every stock specific sub, pretty much. People want their echo chamber where everyone agrees with them. I remember when there weren't any stock specific subs, now there's countless. Some of that has spilled into subs like this, too - there's so much less of the back-and-forth discussions there used to be on here. People talk their book and if they ask for opinions, so many times it's clear that they only want to hear positive ones. SMRs are interesting but you have something like OKLO where you won't have a reactor until 2027 and there are massive energy needs today. Inevitably, with stuff like this there's going to be a lot of low quality speculative stuff that is maybe going to be minimally successful or not at all. Maybe there's one or two eventual successes, but people get so far ahead of themselves that along the way the stock craters because it should have never been where it was in the first place - and you've seen that with OKLO. I remember when shroom stocks were soaring in 2020/21 because people were talking as if everyone was going to be using them as therapy tomorrow. CMPS went to 50 and it's now 5. Not a fan of the EV theme, but RIVN going public at $100B valuation without having delivered a car. Since covid, investing has been highly, highly focused on narratives. Some of these narratives work out really well. Some of them get way ahead of the reality or simply overhype something that wasn't a sustainable business in the first place. I remember when BYND ipo'd and people were talking on here as if that was all everyone was going to eat in the future when the stock went to $200+. It's now 64 cents a share.

Practical-Search-187

CMPS 🚀🚀🚀🚀🍄

Mental-Analysis8911

CMPS 🍄‍🟫

Happy-Let-8808

CMPS

catfromgarfield

CMPS

Stock_Transition6085

My view, there are two companies with more advanced pipeline. CMPS will likely be approved this year and ATAI is 2-3 years behind.

Competitive-Ad4708

CMPS Thursday